Canada Spends Logo

Explore our Budget 2026 analysis

Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)

McGill University

$120,000.00

Investigating mechanisms underlying common Purkinje cell resilience and vulnerability in rare ataxias

FY 2025-26

Summary
Locomotion disorders known as ataxias are a devastating neurological condition characterized by motor incoordination. Ataxia is often caused by damage to the cerebellum, a brain region important for movement. Currently, there is no cure for most ataxias, as disorder mechanisms are poorly understood, especially in rare ataxias, such as autosomal-recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) or Christianson syndrome (CS), a devastating disorder where patients often use walking supports from childhood. Death of Purkinje cells (PC), main neurons of the cerebellum, is a hallmark of ataxia. In CS, ARSACS and many other ataxias, not all PC have equal vulnerability: those in the anterior cerebellum die, while those in the posterior survive. Neurons communicate using electrical signals, called cell firing. In CS and ARSACS, anterior PC fire less than normal, before PC loss and ataxia. To see if any genes contribute to dysfunctions in the vulnerable anterior, we performed gene analysis in CS and ARSACS. In both ataxias, we found, only in the anterior, a large decrease in Scn4b, a major cell firing regulator. It was previously shown that removing Scn4b in healthy mice lowers PC firing rates and causes ataxia. Since firing problems often arise before ataxia, targeting the Scn4b protein decrease to improve PC firing problems may lead to new therapeutic strategies that could alleviate multiple ataxias, despite diverse genetic causes. We will use proof-of-principle gene therapy to increase Scn4b protein levels in anterior cerebellar PC to see if it rescues ataxia. We will also tease apart if PC with firing problems are those that die, a question still unanswered in the field. This will indicate if we must treat firing deficits and cell death separately. This could lead to new ways of treating ataxias, offering novel therapeutic opportunities to patients, greatly improving their quality of life.
Program
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
560184
Name
Tourbina-Kolomiets Julia
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
Investigating mechanisms underlying common Purkinje cell resilience and vulnerability in rare ataxias
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Arsacs; Ataxia; Cerebellum; Christianson Syndrome; Confocal Microscopy; Electrophysiology; Firing; Purkinje Cell; Scn4b; Viral Injection
Abstract
Locomotion disorders known as ataxias are a devastating neurological condition characterized by motor incoordination. Ataxia is often caused by damage to the cerebellum, a brain region important for movement. Currently, there is no cure for most ataxias, as disorder mechanisms are poorly understood, especially in rare ataxias, such as autosomal-recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) or Christianson syndrome (CS), a devastating disorder where patients often use walking supports from childhood. Death of Purkinje cells (PC), main neurons of the cerebellum, is a hallmark of ataxia. In CS, ARSACS and many other ataxias, not all PC have equal vulnerability: those in the anterior cerebellum die, while those in the posterior survive. Neurons communicate using electrical signals, called cell firing. In CS and ARSACS, anterior PC fire less than normal, before PC loss and ataxia. To see if any genes contribute to dysfunctions in the vulnerable anterior, we performed gene analysis in CS and ARSACS. In both ataxias, we found, only in the anterior, a large decrease in Scn4b, a major cell firing regulator. It was previously shown that removing Scn4b in healthy mice lowers PC firing rates and causes ataxia. Since firing problems often arise before ataxia, targeting the Scn4b protein decrease to improve PC firing problems may lead to new therapeutic strategies that could alleviate multiple ataxias, despite diverse genetic causes. We will use proof-of-principle gene therapy to increase Scn4b protein levels in anterior cerebellar PC to see if it rescues ataxia. We will also tease apart if PC with firing problems are those that die, a question still unanswered in the field. This will indicate if we must treat firing deficits and cell death separately. This could lead to new ways of treating ataxias, offering novel therapeutic opportunities to patients, greatly improving their quality of life.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Tourbina-Kolomiets, Julia
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~
McGill University - $120,000 Grant (2025-26) | Canada Spends